Chemkart India Limited (BOM:544442)

Market Cap	1.69B
Revenue (ttm)	1.93B +47.2%
Net Income	187.87M +145.3%
EPS	13.26 +64.6%
Shares Out	12.10M
PE Ratio	10.56
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,200
Average Volume	16,200
Open	150.00
Previous Close	150.00
Day's Range	145.00 - 155.00
52-Week Range	87.00 - 262.00
Beta	n/a
RSI	54.73
Earnings Date	May 18, 2026

About Chemkart India

Chemkart India Limited engages in the trading of various food and health ingredients in India. It offers amino acids, health supplements, herbal extracts, nucleotides, proteins, and vitamins, as well as sports nutrition products. The company also provides nutritional supplements and components, such as glycine, creatine monohydrate 200mesh, inositol, L-arginine, L-glutamine, L-carmitne, N-acetyl L-cysteine, taurine, L-glutathione, and whey protein concentrate. In addition, it engages in the trading and processing of nutraceutical products. The ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2020
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544442

Financial Performance

In fiscal year 2025, Chemkart India's revenue was 2.03 billion, an increase of 53.97% compared to the previous year's 1.32 billion. Earnings were 245.33 million, an increase of 68.98%.